RhythmAnalytics vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

RhythmAnalytics

by Biofourmis Singapore Pte.

prolaio eVO2peak Module

by Prolaio

AI Verdict

Tool A, RhythmAnalytics, specializes in the automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for rhythm abnormalities. In contrast, Tool B, prolaio eVO2peak Module, focuses on estimating peak oxygen consumption (eVO2peak) using a combination of ECG, accelerometry, and demographic data to assess cardiovascular fitness. While both are FDA-cleared cardiology AI tools that utilize ECG data for clinical decision support, their primary analytical outputs and the specific clinical questions they address are distinct.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of single-lead ECG data to detect and classify a wide range of cardiac arrhythmias. This tool is ideal for healthcare professionals seeking enhanced clinical decision support for the rapid identification and management of rhythm disturbances, leveraging its capability to process beat-by-beat morphology and provide detailed rhythm analysis.

View RhythmAnalytics →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if your objective is to estimate peak oxygen consumption (eVO2peak) using real-world patient data from wearable sensors for cardiovascular research and care. This software is best suited for clinicians and researchers who require an adjunctive aid to evaluate a patient's functional capacity and cardiovascular fitness, enabling high-density, longitudinal data collection for risk stratification and personalized care planning.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	RhythmAnalytics	prolaio eVO2peak Module
Pricing	Contact vendor	Contact for pricing
Deployment	Cloud-based API	Cloud-based (software-only, processes remote sensor data)
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

RhythmAnalytics

RhythmAnalytics is offered as a cloud-based API for integration, with general usability tests confirming ease of login, upload, review, and download for integrators and healthcare professionals. Its parent company, Biofourmis, emphasizes a user-friendly dashboard and communication interface within its broader platform, and provides clear setup instructions for its patient app. While Prolaio aims for an intuitive platform and offers technical support for device setup, RhythmAnalytics provides more explicit details regarding its usability for its primary users and integration partners.

Clinical Value

RhythmAnalytics

RhythmAnalytics provides automated, cardiologist-level interpretation of over 15 types of cardiac arrhythmias from single-lead ECG data, offering direct clinical decision support with high sensitivity and specificity. Prolaio's eVO2peak Module estimates peak oxygen consumption as an adjunctive aid, which is valuable for cardiovascular assessment and research, and has met target accuracy in clinical validation. However, RhythmAnalytics' direct diagnostic interpretation of a wide range of arrhythmias offers a more immediate and critical impact on clinical decision-making.

Pricing & Value

Tie

Both tools list their pricing as 'contact vendor' or 'contact for pricing,' which is typical for enterprise healthcare AI solutions. While both companies claim to deliver value through improved patient outcomes and cost efficiencies, neither provides specific pricing models or detailed value propositions that would allow for a comparative assessment. Therefore, it is not possible to distinguish between them on this dimension.

Enterprise Readiness

prolaio eVO2peak Module

Both tools are cloud-based, FDA-cleared, and HIPAA compliant. However, Prolaio explicitly states that a Business Associate Agreement (BAA) is available ('has_baa: 1'), which is a crucial component for enterprise readiness when handling Protected Health Information (PHI). Additionally, Prolaio holds ISO 13485:2016 and MDSAP certifications, further demonstrating a robust quality management system essential for enterprise deployments.

Innovation

prolaio eVO2peak Module

RhythmAnalytics demonstrates innovation through its highly accurate, deep learning-based arrhythmia detection from single-lead ECGs, trained on a vast dataset. Prolaio's eVO2peak Module, however, presents a more novel application of AI by estimating peak oxygen consumption using a unique combination of multi-modal real-world data inputs, including demographic data, single-lead ECG, and triaxial accelerometry from wearable sensors. This multi-modal data fusion for a specific physiological estimation represents a slightly more innovative approach.

Support & Docs

RhythmAnalytics

Biofourmis, the company behind RhythmAnalytics, explicitly outlines comprehensive support, including 'Superior service & support,' 'Dedicated on-site resources,' and '24/7/365 clinical support' and '24/7/365 IT support'. While Prolaio mentions providing 'technical support' for study participants and holds ISO certification implying structured support, it does not detail the same breadth, availability, or explicit support channels as Biofourmis. Therefore, Tool A appears to offer more robust and clearly defined support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	RhythmAnalytics	prolaio eVO2peak Module
Name	RhythmAnalytics	prolaio eVO2peak Module
Company	Biofourmis Singapore Pte.	Prolaio
Description	FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators.	FDA-cleared software to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care.
Key Functionality	AI-based automated interpretation of cardiac arrhythmias; Detection of over 15 types of cardiac arrhythmias; Beat-by-beat morphology computation; ECG signal processing and analysis; QRS and Ventricular Ectopic Beat detection; QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis.	Estimates peak oxygen consumption (eVO2peak); Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs; Processes data from qualified third-party FDA-cleared wearable medical sensors; Applies a locked deep-learning model for eVO2peak estimation; Provides information as an adjunctive aid in clinical evaluation.
Specialties	Cardiology, Emergency Medicine, Internal Medicine	Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and prolaio eVO2peak Module.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical difference in the utility of RhythmAnalytics versus the prolaio eVO2peak Module?

RhythmAnalytics by Biofourmis is an AI-powered cloud-based software designed for the automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data, serving as an adjunctive aid in clinical evaluation for cardiovascular research and care.

What types of patient data are required for each tool?

RhythmAnalytics primarily requires single-lead ECG data for its analysis. The prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.

What specific cardiac conditions or metrics do these tools help assess?

RhythmAnalytics detects over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats, and provides rhythm analysis. The prolaio eVO2peak Module specifically estimates peak oxygen consumption (eVO2peak), a metric related to cardiovascular fitness and functional capacity.

How do these tools integrate with existing medical devices or systems?

RhythmAnalytics is deployed as a cloud-based API for integration and is compatible with FDA-cleared ECG devices such as Holter monitors, event recorders, and wearable sensors. The prolaio eVO2peak Module is also cloud-based software that processes data from qualified third-party FDA-cleared wearable medical sensors.

What kind of output or insights can I expect from each tool?

RhythmAnalytics provides AI-based automated interpretation of cardiac arrhythmias, including beat-by-beat morphology computation, QRS and ventricular ectopic beat detection, and heart rate measurement. The prolaio eVO2peak Module provides an estimation of peak oxygen consumption (eVO2peak) as an adjunctive aid in clinical evaluation, leveraging a locked deep-learning model.